v3.26.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Current assets    
Cash $ 4,370 $ 2,620
Accounts receivable 5,000 5,000
Due from related party 17,592 17,592
Prepaid expense and other current assets 4,500 2,319
Total current assets 31,462 27,531
Patents and trademarks, net 84,849 100,036
Total assets 116,311 127,567
Current liabilities    
Accounts payable and accrued liabilities 1,501,666 1,253,669
Accrued interest payable 3,785,404 3,357,157
Loans from related party 135,945 45,044
Notes payable 10,000 10,000
Convertible notes payable 352,075 352,075
Total current liabilities 5,785,090 5,017,945
Convertible notes payable related party 5,372,403 5,372,403
Total liabilities 11,157,493 10,390,348
Stockholders' deficit    
Common stock; $0.001 par value; 200,000,000 shares authorized; 5,403,843 and 5,403,843 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively 5,404 5,404
Additional paid-in capital 30,741,991 30,741,991
Accumulated deficit (41,788,577) (41,010,176)
Total stockholders' deficit (11,041,182) (10,262,781)
Total liabilities and stockholders' deficit $ 116,311 $ 127,567